comparemela.com

Latest Breaking News On - Ono pharmaceutical - Page 6 : comparemela.com

Ono Pharma's Plan to Become a Global Player Picks Up a New Piece With $2.4B Deciphera Acquisition

Ono Pharma's Plan to Become a Global Player Picks Up a New Piece With $2.4B Deciphera Acquisition
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

Massachusetts
United-states
Connecticut
Waltham
Japan
Japanese
Gyo-sagara
Europeans-medicines-agency
Bristol-myers-squibb
Mono-group
Ono-pharmaceutical
Deciphera-pharmaceutical

Japan's ONO pays $2.4 billion for Qinlock-maker Deciphera

Japan's ONO pays $2.4 billion for Qinlock-maker Deciphera
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Osaka
Japan
Massachusetts
United-states
Waltham
Gyo-sagara
Bristol-myers-squibb
Deciphera-pharmaceuticals
Ono-pharmaceutical
Cymabay-therapeutics
Shattuck-labs

Ono Pharmaceutical acquires Deciphera Pharmaceuticals for $2.4B

The $2.4 billion deal will bring Deciphera’s cancer drugs Qinlock, vimseltinib and DCC-3116 under Ono Pharmaceutical’s umbrella.

Massachusetts
United-states
Japan
Japanese
Gyo-sagara
Steven-hoerter
Ambrx-biopharma
Mono-group
Escient-pharmaceuticals
Drug-administration
Deciphera-pharmaceuticals
Ono-pharmaceutical

CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb's Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma

Recommendation based on results from CheckMate -901, the first Phase 3 trial with an immunotherapy-chemotherapy combination to demonstrate a survival benefit versus standard-of-care chemotherapy.

United-states
Japan
Taiwan
South-korea
China
Bristol-myers-squibb
Dana-walker
European-medicines-agency
Company-opdivo
Twitter
Instagram
Global-program

Next-Gen PARP Inhibitor Shows Benefit in Breast Cancer Patients

Next-Gen PARP Inhibitor Shows Benefit in Breast Cancer Patients
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Oregon
United-states
Hong-kong
United-kingdom
Switzerland
Texas
Swiss
American
Haihe-biopharma
Biocity-biopharma
Calithera-biosciences
Terremoto-biosciences

vimarsana © 2020. All Rights Reserved.